PCM
IMVT icon

Pinz Capital Management’s Immunovant IMVT Stock Holding History

Pinz Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-199,100
Closed -$7.01M – 157
2020
Q3 		$7.01M Buy
+199,100
New +$5.99M 2.56% 6

Other funds holding IMVT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pinz Capital Management's IMVT Position: Q4 2020 in Review

Pinz Capital Management sold out of Immunovant (IMVT) in Q4 2020, closing a stake of 199,100 shares — an estimated $7.01M sold.

Pinz Capital Management first reported a position in IMVT in Q3 2020 and held it in 1 quarter. The position peaked at $7.01M in Q3 2020. 147 funds tracked by Wall St. Rank hold IMVT as of Q4 2020.

  • Pinz Capital Management reported no remaining Immunovant position as of Q4 2020 after selling out during the quarter.
  • Pinz Capital Management sold 199,100 Immunovant shares in Q4 2020, an estimated $7.01M.
  • Pinz Capital Management first reported a position in Immunovant in Q3 2020 and held it in 1 quarter.
  • Pinz Capital Management's Immunovant position peaked at $7.01M in Q3 2020.
  • 147 funds tracked by Wall St. Rank held Immunovant as of Q4 2020.

Based on Pinz Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.